Polar Asset Management Partners’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-154,800
| Closed | -$223K | – | 745 |
|
|
2024
Q3 | $223K | Hold |
154,800
| – | – | ﹤0.01% | 468 |
|
|
2024
Q2 | $198K | Hold |
154,800
| – | – | ﹤0.01% | 431 |
|
|
2024
Q1 | $585K | Hold |
154,800
| – | – | 0.01% | 441 |
|
|
2023
Q4 | $797K | Buy |
+154,800
| New | +$797K | 0.01% | 415 |
|
|
2020
Q3 | – | Sell |
-459,920
| Closed | -$4.94M | – | 654 |
|
|
2020
Q2 | $4.94M | Buy |
459,920
+99,013
| +27% | +$1.06M | 0.08% | 180 |
|
|
2020
Q1 | $3.8M | Sell |
360,907
-19,893
| -5% | -$209K | 0.08% | 176 |
|
|
2019
Q4 | $3.99M | Buy |
380,800
+330,800
| +662% | +$3.47M | 0.08% | 199 |
|
|
2019
Q3 | $518K | Hold |
50,000
| – | – | 0.01% | 282 |
|
|
2019
Q2 | $513K | Hold |
50,000
| – | – | 0.01% | 268 |
|
|
2019
Q1 | $504K | Hold |
50,000
| – | – | 0.01% | 228 |
|
|
2018
Q4 | $492K | Buy |
+50,000
| New | +$492K | 0.01% | 220 |
|